134 results
8-K
EX-10.1
HRGN
Harvard Apparatus Regenerative Technology, Inc.
17 Apr 24
Entry into a Material Definitive Agreement
5:08pm
.
(y) Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse … and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental
8-K
EX-10.1
qsl0e q430k8do0
6 Apr 23
Biostage Announces $6 Million Financing to Advance Clinical Trial
10:10am
8-K
EX-10.1
q23b5u
10 Aug 22
Biostage Announces Appointment of New Chief Financial Officer
12:00am